Skip to main content
. Author manuscript; available in PMC: 2018 Dec 1.
Published in final edited form as: Hepatology. 2017 Oct 30;66(6):1952–1967. doi: 10.1002/hep.29374

Fig. 1.

Fig. 1

miR-206 expression was reduced in HCC tumors of human and mouse. (A) Reduced expression of miR-206 in livers of AKT/Ras (n=6) and cMyc (n=6) HCC mouse models compared to normal mice (n=6). qRT-PCR was used to determine expression of miR-206. NL: normal liver. (B) Levels of miR-206 in human HCC cell lines with divergent backgrounds compared with normal human hepatocytes as revealed by qRT-PCR. (C) Decreased expression of miR-206 in human HCC tumors (n=26) versus normal liver tissues (n=19). Mann-Whitney test was used to evaluate the statistical significance. Data represent mean ± SEM. **p < 0.01 and ***p < 0.001.